- Home
- COLA vs NSPR Comparison
COLA vs NSPR Comparison
Compare COLA & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COLA
- NSPR
- Stock Information
- Founded
- COLA 2024
- NSPR 2005
- Country
- COLA Singapore
- NSPR United States
- Employees
- COLA N/A
- NSPR N/A
- Industry
- COLA
- NSPR Medical/Dental Instruments
- Sector
- COLA
- NSPR Health Care
- Exchange
- COLA NYSE
- NSPR Nasdaq
- Market Cap
- COLA 79.8M
- NSPR 74.8M
- IPO Year
- COLA 2025
- NSPR N/A
- Fundamental
- Price
- COLA $10.18
- NSPR $2.43
- Analyst Decision
- COLA
- NSPR Strong Buy
- Analyst Count
- COLA 0
- NSPR 2
- Target Price
- COLA N/A
- NSPR $4.50
- AVG Volume (30 Days)
- COLA 383.0
- NSPR 85.8K
- Earning Date
- COLA 01-01-0001
- NSPR 08-05-2025
- Dividend Yield
- COLA N/A
- NSPR N/A
- EPS Growth
- COLA N/A
- NSPR N/A
- EPS
- COLA N/A
- NSPR N/A
- Revenue
- COLA N/A
- NSPR $7,027,000.00
- Revenue This Year
- COLA N/A
- NSPR $4.85
- Revenue Next Year
- COLA N/A
- NSPR $113.47
- P/E Ratio
- COLA N/A
- NSPR N/A
- Revenue Growth
- COLA N/A
- NSPR 8.49
- 52 Week Low
- COLA $9.95
- NSPR $1.99
- 52 Week High
- COLA $10.18
- NSPR $3.80
- Technical
- Relative Strength Index (RSI)
- COLA N/A
- NSPR 52.46
- Support Level
- COLA N/A
- NSPR $2.24
- Resistance Level
- COLA N/A
- NSPR $2.55
- Average True Range (ATR)
- COLA 0.00
- NSPR 0.14
- MACD
- COLA 0.00
- NSPR 0.02
- Stochastic Oscillator
- COLA 0.00
- NSPR 59.51
About COLA COLUMBUS ACQUISITION CORP
Columbus Acquisition Corp is a blank check company.
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.